相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epileptic features and survival in glioblastomas presenting with seizures
Manuel Toledo et al.
EPILEPSY RESEARCH (2017)
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients
Javier M. Figueroa et al.
NEURO-ONCOLOGY (2017)
Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma
Julia Tichy et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma
Xiao Yue et al.
JOURNAL OF NEUROSURGERY (2016)
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
N-s Lai et al.
BRITISH JOURNAL OF CANCER (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma
Hailin Tang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients
Johnny C. Akers et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
Aida Kiviniemi et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
Marc Aubry et al.
ONCOTARGET (2015)
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
Alessandra Drusco et al.
ONCOTARGET (2015)
Economics of Malignant Gliomas: A Critical Review
Jeffrey J. Raizer et al.
JOURNAL OF ONCOLOGY PRACTICE (2015)
Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information
Lina Moren et al.
METABOLITES (2015)
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
Kelly M. MacArthur et al.
CANCER RESEARCH (2014)
miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients
Lun Dong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Lorea Manterola et al.
NEURO-ONCOLOGY (2014)
Early presentation of primary glioblastoma
R. Faguer et al.
NEUROCHIRURGIE (2014)
Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas
Fang Shen et al.
NEUROSURGICAL REVIEW (2014)
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
James P. Sullivan et al.
CANCER DISCOVERY (2014)
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
Aleksandra Majchrzak-Celinska et al.
JOURNAL OF APPLIED GENETICS (2013)
Factors associated with survival for patients with glioblastoma with poor pre-operative functional status
Kaisorn L. Chaichana et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Comparison of Survival Between Cerebellar and Supratentorial Glioblastoma Patients: Surveillance, Epidemiology, and End Results (SEER) Analysis
Sunil Jeswani et al.
NEUROSURGERY (2013)
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
Johnny C. Akers et al.
PLOS ONE (2013)
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
Mikkel Noerholm et al.
BMC CANCER (2012)
Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma
Jason W. Locasale et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Huilin Shao et al.
NATURE MEDICINE (2012)
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
Nadiya M. Teplyuk et al.
NEURO-ONCOLOGY (2012)
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Hina Kalra et al.
PLOS BIOLOGY (2012)
Identification of diagnostic serum protein profiles of glioblastoma patients
Anja Elstner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival Clinical article
Kaisorn L. Chaichana et al.
JOURNAL OF NEUROSURGERY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Long-term outcomes in children with glioblastoma Clinical article
Kyung Sun Song et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features
Rafael Benito et al.
NEUROPATHOLOGY (2010)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
Amy B. Heimberger et al.
CLINICAL CANCER RESEARCH (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
Adilia Hormigo et al.
CLINICAL CANCER RESEARCH (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)